John Bishop

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for John Bishop
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Bishop:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARDELYX, INC. Chief Technical Operations Officer Exhibit 24.1 - Power of Attorney Common Stock 218,000 $1,201,180 $5.51 01 Aug 2025 Direct
Lyra Therapeutics, Inc. Chief Technology Officer Stock Options 200,000 30 Jan 2024 Direct
Forma Therapeutics Holdings, Inc. SVP, Chief Technology Officer Common Stock 0 $5.05 14 Oct 2022 Direct
Forma Therapeutics Holdings, Inc. SVP, Chief Technology Officer Stock Option (Right to Buy) 0 14 Oct 2022 Direct

Insider Reports Filed by John Bishop

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARDX ARDELYX, INC. 01 Aug 2025 0 $0 3 Chief Technical Operations Officer Exhibit 24.1 - Power of Attorney 17 Oct 2025, 18:18
LYRA Lyra Therapeutics, Inc. 30 Jan 2024 1 $0 4 Chief Technology Officer 01 Feb 2024, 16:15
LYRA Lyra Therapeutics, Inc. 27 Feb 2023 1 $0 4 Chief Technology Officer 28 Feb 2023, 15:10
LYRA Lyra Therapeutics, Inc. 27 Feb 2023 0 $0 3 Chief Technology Officer 28 Feb 2023, 15:05
FMTX Forma Therapeutics Holdings, Inc. 14 Oct 2022 3 $0 4 SVP, Chief Technology Officer 14 Oct 2022, 16:06
FMTX Forma Therapeutics Holdings, Inc. 28 Feb 2022 2 $0 4 SVP, Chief Technology Officer 02 Mar 2022, 16:14
FMTX Forma Therapeutics Holdings, Inc. 14 Jun 2021 2 $0 4 Chief Technology Officer 15 Jun 2021, 16:15
FMTX Forma Therapeutics Holdings, Inc. 14 Jun 2021 0 $0 3 Chief Technology Officer 15 Jun 2021, 16:12